Chicory root prebiotic for mood and stress in adults with mild to moderate anxiety
Official title: The Effects of Chicory Root-derived Prebiotic on Mood and Stress Responsiveness in Healthy Adults With Mild to Moderate Levels of Stress and Anxiety: a Randomized, Placebo-controlled, Double-blind, Monocentric, Two-armed Parallel, Prospective Study - The PRIME Study
Run by Beneo-Institute · NCT07058324 · Data updated 2026-11-12
This study will test whether a chicory root–derived prebiotic can help reduce stress and mild to moderate anxiety in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 204 (estimated) |
| Sponsor | Beneo-Institute Industry-sponsored |
| Locations | 1 site (Trier, Rhineland-Palatinate) |
| Status | Recruiting |
| Started | June 2, 2025 |
| Main results expected | June 2026 |
| Study ends | August 2026 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT07058324 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18–70 with mild to moderate anxiety (GAD score 5–14), elevated chronic stress screening scores, BMI 18.5–29.9, and no major medical, psychiatric, or gastrointestinal conditions.
✕Probably not a fit
People with diagnosed neurological or psychiatric disorders, significant medical illnesses (renal, hepatic, cardiovascular, diabetes), gastrointestinal diseases like IBS/IBD, severe anxiety, or those outside the age/BMI ranges may not benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy adults with mild to moderate anxiety will be enrolled and must meet screening thresholds for chronic stress and GAD scores; people with major medical, psychiatric, or gastrointestinal disorders are excluded. Participants will receive either a chicory root–derived prebiotic fiber or a matching placebo and will follow study instructions for the intervention period. Mood and stress responsiveness will be measured with standardized questionnaires and behavioral/physiological assessments over the course of the treatment. The trial is sponsored by the Beneo-Institute and run at a CRO site in Trier, Germany.
Why it matters
Potential benefit: If successful, this could provide a safe, diet-based option to help reduce stress and mild-to-moderate anxiety symptoms.
How similar studies have gone: Preclinical work and a few small human studies of prebiotic fibers have suggested possible mood and stress benefits, but results so far are preliminary and not definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Volunteer is healthy at the time of screening. 2. TICS Screening Scale of Chronic Stress (SSCS) score ≥ 6. 3. GAD total score ≥ 5 and ≤ 14 indicating mild to moderate anxiety. 4. Male or female aged ≥18 and ≤ 70 years at the time of screening. 5. Body-Mass-Index (BMI) ≥ 18.5 and ≤ 29.9 kg/m2. 6. Volunteer is able and willing to comply with the study instructions. 7. Volunteer is suitable for participation in the study according to the investigator/study personnel. 8. Voluntary, written informed consent to participate in the study. Exclusion Criteria: 1. No command of local language. 2. Previously or currently diagnosed neurological or psychiatric disorders. 3. Previous history of renal, hepatic, cardiovascular disease or clinically significant diabetes. 4. Gastrointestinal disorders including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) or other conditions that might affect the gut environment. 5. Contraindication or allergy to any substance in the verum or placebo product incl. lactose or fructose intolerance. 6. Use of drugs (e.g., antibiotics, aspirin, proton pump inhibitors) influencing gastrointestinal function in the previous 8 weeks before the beginning of intervention. 7. Use of laxatives and labelled pre-and probiotics in the previous 4 weeks before the beginning of intervention. 8. Participation in another study with any investigational product within 30 days of screening or during the study. 9. History of drug (recreational) or alcohol abuse. 10. Use of anti-depressants medication including selective serotonin receptor inhibitors or amitriptyline for 3 months prior to screening. 11. Bowel preparation for investigative procedures in the 4 weeks prior to screening. 12. Surgical resection of any part of the bowel. 13. Pregnant or lactating. 14. Regular smoking. 15. Previous Trier Social Stress Test (TSST) participation.
Where it's running
-
daacro GmbH & Co. KG
Trier, Rhineland-Palatinate, Germany Recruiting
Study contacts
- Principal investigator: Juliane Hellhammer, Ph.D. — Daacro GmbH & Co. KG
- Study coordinator: Yoghatama Cindya Zanzer, Ph.D.
- Email: YoghatamaCindya.Zanzer@beneo.com
- Phone: +496359803-9756
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
Training to reduce oxidative stress in knee OA
A six-week program compares supervised knee-strengthening training with a daily 6,000-step walking plan to see if it improves pain, function, and blood markers of cellular stress in people with knee osteoarthritis.
-
Ashwagandha with resistance training to boost strength and stress markers
This 12-week study tests whether taking ASHWAGANDHA along with regular resistance training helps healthy, trained men see improvements in strength, stress levels, sleep, and cognitive function compared with a placebo.
-
Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis
This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.